Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    BioCryst Pharmaceuticals ...

    NASDAQ: BCRX · Real-Time Price · USD
    8.31
    -0.07 (-0.84%)
    At close: Aug 19, 2025, 10:15 AM

    BioCryst Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 104.71M 110.64M 304.77M 504.39M
    Short-Term Investments
    		 216.14M 278.34M 119.54M 3.21M
    Long-Term Investments
    		 20.32M n/a 18.08M 6.83M
    Other Long-Term Assets
    		 28.34M 80K 6.81M n/a
    Receivables
    		 79.07M 56.95M 50.6M 29.41M
    Inventory
    		 8.09M 28.68M 27.53M 15.79M
    Other Current Assets
    		 13.96M 1.8M 1.47M 3.35M
    Total Current Assets
    		 421.97M 495.97M 516.5M 566.14M
    Property-Plant & Equipment
    		 19.79M 20.91M 15.42M 15.19M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 68.45M 20.99M 33.5M 22.02M
    Total Assets
    		 490.42M 516.96M 550M 588.15M
    Account Payables
    		 11.64M 20.89M 14.36M 27.81M
    Deferred Revenue
    		 n/a n/a 1.22M 1.42M
    Short-Term Debt
    		 32.68M 23.57M n/a n/a
    Other Current Liabilities
    		 64.66M 66.36M 65.44M 52M
    Total Current Liabilities
    		 160.38M 149.99M 105.51M 103.72M
    Long-Term Debt
    		 795.92M 811.26M 733.28M 585.46M
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 805.97M 822.5M 739.08M 591.42M
    Total Liabilities
    		 966.35M 972.49M 844.6M 695.14M
    Total Debt
    		 841.42M 848.71M 741.45M 593.24M
    Common Stock
    		 2.08M 2.06M 1.88M 1.84M
    Retained Earnings
    		 -1.77B -1.68B -1.45B -1.21B
    Comprehensive Income
    		 921K 1.34M 26K 177K
    Shareholders Equity
    		 -475.93M -455.53M -294.6M -106.99M
    Total Investments
    		 236.46M 278.34M 137.62M 10.04M

    Add to Watchlist